OMER Nov 2024 2.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:53PM EDT. Market open.
| Previous Close | 1.4600 |
| Open | N/A |
| Bid | 1.3000 |
| Ask | 1.8500 |
| Strike | 2.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 1.4600 - 1.4600 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 5 |
Business WireOmeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028
SEATTLE, June 03, 2024--Omeros Corporation (Nasdaq: OMER) today announced that it has completed a series of strategic financial transactions, further strengthening its balance sheet and extending the maturity profile on a substantial portion of its debt from February 2026 to June 2028, while providing a secure source of capital to support potential commercialization of its lectin pathway inhibitor narsoplimab and flexibility to manage the remaining balance of 2026 convertible notes.
- GuruFocus.com
Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...
Amidst a significant net loss increase, Omeros Corp navigates through promising drug trials and strategic royalty milestones.
© 2024 Yahoo. All rights reserved.